Gene: C17orf113
Official Full Name: chromosome 17 open reading frame 113provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19151 | C17orf113 Knockout cell line (HEK293) | Human | C17orf113 | 1:3~1:6 | Negative | Online Inquiry |
C17orf113 Gene Knockout Cell Lines are advanced cellular models specifically engineered to lack the expression of the C17orf113 gene, a gene implicated in various biological processes and potential disease mechanisms. These knockout cell lines serve as invaluable tools for researchers aiming to elucidate the functional roles of C17orf113 in cellular pathways, disease states, and therapeutic responses.
The primary function of these cell lines lies in their ability to provide a controlled environment for studying gene function through genetic loss-of-function approaches. By utilizing CRISPR/Cas9 technology, the C17orf113 gene is precisely disrupted, thereby enabling scientists to observe alterations in cellular behavior, including growth patterns, metabolic changes, and responses to external stimuli. This targeted disruption plays a crucial role in identifying the contributions of C17orf113 to cellular mechanisms and its potential links to diseases such as cancer or neurodegenerative disorders.
The scientific significance of C17orf113 Gene Knockout Cell Lines extends to a wide array of applications, including drug discovery, gene therapy research, and the development of personalized medicine strategies. By leveraging these knockout models, researchers can derive insights into the pathogenic mechanisms associated with C17orf113 and evaluate new therapeutic targets.
What sets our C17orf113 Gene Knockout Cell Lines apart from other genetic models is the high specificity and efficacy of the genomic editing process, ensuring that off-target effects are minimized. This precision allows for reliable and reproducible experimentation, making our product a superior choice over conventional knockout models.
For researchers and clinicians, the value of adopting C17orf113 Gene Knockout Cell Lines lies in their potential to accelerate discovery and enhance understanding of complex biological phenomena, ultimately paving the way for innovative therapeutic approaches.
At [Company Name], our commitment to advancing scientific knowledge drives us to provide state-of-the-art biological products, ensuring our customers have the tools necessary to make groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.